Ownership

Sekar Kathiresan - Chief Executive Officer, Director at Verve Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type: Individual
Role: Chief Executive Officer, Director
Stock Symbol: VERV on Nasdaq
Industry: Pharmaceutical Preparations
All Insider Reports: All Insider Reports

There are no Buy or Sell transactions made by Sekar Kathiresan since 3/10/2024

Holdings reported by Sekar Kathiresan for Verve Therapeutics, Inc.

Class	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Common Stock	324K	$1.82M	$5.64	Dec 4, 2024	Direct
Common Stock	241K	$1.36M	$5.64	Dec 4, 2024	Kathiresan Family 2021 Irrevocable Trust
Restricted Stock Units	120K	$677K	$5.64	Jan 8, 2025	Direct	Common Stock
Common Stock	111K	$626K	$5.64	Dec 4, 2024	Sekar Kathiresan 2021 Irrevocable Trust
Stock Option (right to buy)	150K			Jan 8, 2025	Direct	Common Stock

Showing 1 to 5 of 5 entries

Transactions reported by Sekar Kathiresan for Verve Therapeutics, Inc.

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.